Community unites to honor Matlacha victim with memorial gardenLocal postal workers union raises alarm over mail delivery delays
Former Turing Pharmaceuticals CEO Martin Shkreli, left, arrives to federal court with his attorney Benjamin Brafman in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys’ advice to lay low. (AP Photo/Seth Wenig) NEW YORK (AP) Several prospective jurors have been excused from the federal securities fraud trial of an ex-pharmaceutical company executive because they claimed they couldn’t be impartial. Jury selection will continue Tuesday morning in Brooklyn. During jury questioning Monday, several potential jurors said they couldn’t ignore Martin Shkreli’s reputation for raising the price of a life-saving drug by 5,000 percent. One of them called him “the face of corporate greed.” Another said he’s “the most hated man in America.” The 34-year-old Shkreli was arrested last year on conspiracy and other charges unrelated to the price-gouging scandal. Since then, he’s defied his lawyers’ advice to lay low by using social media to boast about his accomplishments and troll his critics. The defense has accused the media of vilifying him.